# Methylphenidate Hydrochloride Controlled-Release Tablets Augmentation Strategy for Patients With Obsessive Compulsive Disorder

> **NCT02194075** · PHASE4 · COMPLETED · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 60 (actual)

## Conditions studied

- Obsessive Compulsive Disorder

## Interventions

- **DRUG:** Fluvoxamine+Methylphenidate hydrochloride
- **DRUG:** Fluvoxamine+sugar pill

## Key facts

- **NCT ID:** NCT02194075
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2015-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02194075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02194075, "Methylphenidate Hydrochloride Controlled-Release Tablets Augmentation Strategy for Patients With Obsessive Compulsive Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02194075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*